O-(2-[18F]Fluoroethyl)-L-tyrosine-PET-based delineation yields similar clinical outcomes to contrast-enhanced T1-weighted MRI for re-irradiation in patients with glioblastoma. Medscape News UK
O-(2-[18F]Fluoroethyl)-L-tyrosine-PET-based delineation yields similar clinical outcomes to contrast-enhanced T1-weighted MRI for re-irradiation in patients with glioblastoma. Medscape News UK